Are you taking Rabeprazole? Are you aware of the dangers of combining Rabeprazole with certain foods and herbs? Drug-food-interactions are seldom discussed but can lead to undesirable side effects and ...

Rabeprazole sodium, a potent antisecretory compound, selectively inhibits gastric acid secretion by targeting the H+ and K+ ATPase at the surface of gastric parietal cells. It has demonstrated ...

Rabeprazole is a proton pump inhibitor, prescribed for duodenal ulcer, gastro esophageal reflux disease (GERD), and Zollinger-Ellison (gastric acid hyper secretion) syndrome. Rabeprazole can cause an ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Aciphex (rabeprazole sodium; Eisai) delayed-release tablets for the treatment of gastroesophageal reflux disease ...

Pune, March 31, 2023 (GLOBE NEWSWIRE) -- A global Healthcare business consulting firm, Maximize Market research, has published a business intelligence report on the “Rabeprazole Sodium Market”. The ...

To investigate whether the pharmacodynamics and pharmacokinetics of rabeprazole are dependent on CYP2C19 genotype status in healthy Chinese Han subjects. The CYP2C19 genotype status of healthy Chinese ...

Pulmonary adverse drug reactions in patients treated with gemcitabine and a combination of gemcitabine and a taxane No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

This leaflet answers some common questions about RABEPRAZOLE MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines ...

Akums Drugs & Pharmaceuticals Ltd., one of the country’s largest India-CDMO serving the Indian domestic pharmaceutical industry, has announced the launch of Rabeprazole + Levosulpiride SR Capsules.

Objective: A high proportion of patients with gastro-oesophageal reflux disease experience recurrence of symptoms within a year of initial treatment. The key to preventing relapse is an effective ...

PRINCETON, N.J. — Kremers Urban Pharmaceuticals, a subsidiary of UCB, announced the launch of rabeprazole sodium delayed-release tablets. The drug is used to treat gastroesophageal reflux disease in ...